YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivo
Tian, Shu, Quan, Haitian, Xie, Chengying, Guo, Haiyi, Lü, Fangfang, Xu, Yongping, Li, Jin, Lou, Liguang
Published in Cancer science (01.07.2011)
Published in Cancer science (01.07.2011)
Get full text
Journal Article
Pharmacologic characterization of fluzoparib, a novel poly(ADP‐ribose) polymerase inhibitor undergoing clinical trials
Wang, Lei, Yang, Changyong, Xie, Chengying, Jiang, Jiahua, Gao, Mingzhao, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Lou, Liguang
Published in Cancer science (01.03.2019)
Published in Cancer science (01.03.2019)
Get full text
Journal Article
STAT3 activation confers trastuzumab‐emtansine (T‐DM1) resistance in HER2‐positive breast cancer
Wang, Lei, Wang, Quanren, Gao, Mingzhao, Fu, Li, Li, Yun, Quan, Haitian, Lou, Liguang
Published in Cancer science (01.10.2018)
Published in Cancer science (01.10.2018)
Get full text
Journal Article
Aberrant intracellular metabolism of T‐DM1 confers T‐DM1 resistance in human epidermal growth factor receptor 2‐positive gastric cancer cells
Wang, Hongbin, Wang, Wenqian, Xu, Yongping, Yang, Yong, Chen, Xiaoyan, Quan, Haitian, Lou, Liguang
Published in Cancer science (01.07.2017)
Published in Cancer science (01.07.2017)
Get full text
Journal Article
Pd-Catalyzed Decarboxylative Olefination: Stereoselective Synthesis of Polysubstituted Butadienes and Macrocyclic P-glycoprotein Inhibitors
Song, Bichao, Xie, Peipei, Li, Yingzi, Hao, Jiping, Wang, Lu, Chen, Xiangyang, Xu, Zhongliang, Quan, Haitian, Lou, Liguang, Xia, Yuanzhi, Houk, K. N., Yang, Weibo
Published in Journal of the American Chemical Society (03.06.2020)
Published in Journal of the American Chemical Society (03.06.2020)
Get full text
Journal Article
Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models
Long, Fei, He, Ye, Fu, Haoyu, Li, Yun, Bao, Xubin, Wang, Quanren, Wang, Yigang, Xie, Chengying, Lou, Liguang
Published in Cancer science (01.04.2019)
Published in Cancer science (01.04.2019)
Get full text
Journal Article
YES1 amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer
Wang, Lei, Wang, Quanren, Xu, Piaopiao, Fu, Li, Li, Yun, Fu, Haoyu, Quan, Haitian, Lou, Liguang
Published in British journal of cancer (01.09.2020)
Published in British journal of cancer (01.09.2020)
Get full text
Journal Article
Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia
Xie, Chengying, He, Ye, Zhen, Mingyue, Wang, Yulan, Xu, Yongping, Lou, Liguang
Published in Cancer science (01.07.2017)
Published in Cancer science (01.07.2017)
Get full text
Journal Article
SHR‐A1403, a novel c‐mesenchymal‐epithelial transition factor (c‐Met) antibody‐drug conjugate, overcomes AZD9291 resistance in non‐small cell lung cancer cells overexpressing c‐Met
Tong, Mengya, Gao, Mingzhao, Xu, Yongping, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Quan, Haitian, Lou, Liguang
Published in Cancer science (01.11.2019)
Published in Cancer science (01.11.2019)
Get full text
Journal Article
Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants
Gao, Mingzhao, Zhu, Hongmei, Fu, Li, Li, Yun, Bao, Xubin, Fu, Haoyu, Quan, Haitian, Wang, Lei, Lou, Liguang
Published in Cancer science (01.10.2019)
Published in Cancer science (01.10.2019)
Get full text
Journal Article
Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells
Wu, Lixian, Yu, Jing, Chen, Ruijia, Liu, Yang, Lou, Liguang, Wu, Ying, Huang, Lisen, Fan, Yingjuan, Gao, Pinzhang, Huang, Meijuan, Wu, Yong, Chen, Yuanzhong, Xu, Jianhua
Published in Clinical cancer research (15.02.2015)
Published in Clinical cancer research (15.02.2015)
Get full text
Journal Article
Third‐generation EGFR inhibitor HS‐10296 in combination with famitinib, a multi‐targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR‐mutant non‐small cell lung cancer cells
Zhang, Mi, Quan, Haitian, Fu, Li, Li, Yun, Fu, Haoyu, Lou, Liguang
Published in Thoracic cancer (01.04.2021)
Published in Thoracic cancer (01.04.2021)
Get full text
Journal Article
Phosphodiesterase 3/4 inhibitor zardaverine exhibits potent and selective antitumor activity against hepatocellular carcinoma both in vitro and in vivo independently of phosphodiesterase inhibition
Sun, Liping, Quan, Haitian, Xie, Chengying, Wang, Lei, Hu, Youhong, Lou, Liguang
Published in PloS one (05.03.2014)
Published in PloS one (05.03.2014)
Get full text
Journal Article
Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
Wang, Wenqian, Liu, Yang, Zhao, Zhixin, Xie, Chengying, Xu, Yongping, Hu, Youhong, Quan, Haitian, Lou, Liguang
Published in Cancer science (01.06.2016)
Published in Cancer science (01.06.2016)
Get full text
Journal Article
Flumatinib, a selective inhibitor of BCR‐ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants
Zhao, Jie, Quan, Haitian, Xu, Yongping, Kong, Xiangqian, Jin, Lu, Lou, Liguang
Published in Cancer science (01.01.2014)
Published in Cancer science (01.01.2014)
Get full text
Journal Article
Cucurbitane-Type Triterpenoids from the Stems of Cucumis melo
Chen, Chuan, Qiang, Shigao, Lou, Liguang, Zhao, Weimin
Published in Journal of natural products (Washington, D.C.) (22.05.2009)
Published in Journal of natural products (Washington, D.C.) (22.05.2009)
Get full text
Journal Article